|
⚲
|
| Keyboard |
| van Nostrand Robert L
✚
|
|
|---|---|
| CIK # | 0001225198 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001225198] | |
| 4 | [0001225198] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SELLAS Life Sciences Group Inc | |
| van Nostrand Robert L | |
| Intra-Cellular Therapies Inc | |
| Yield10 Bioscience Inc | |
| Achillion Pharmaceuticals Inc | |
| Cerulean Group Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2026-01-07 | Grant | 50,000 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2025-06-12 | Buy | 10,000 | $1.48 | 14,800 |
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2025-04-02 | Disposed to issuer | 16,757 | ||
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2025-04-02 | Disposed to issuer | 20,000 | ||
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2025-04-02 | Disposed to issuer | 20,000 | ||
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2025-04-02 | Disposed to issuer | 20,000 | ||
|
Intra-Cellular Therapies Inc ITCI
Common Stock
|
2025-04-02 | Disposed to issuer | 11,340 | $132.00 | 1,496,880 |
|
Intra-Cellular Therapies Inc ITCI
Restricted Stock Units · derivative
|
2025-04-02 | Disposed to issuer | 2,951 | ||
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2025-04-02 | Disposed to issuer | 7,009 | ||
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2025-04-02 | Disposed to issuer | 4,322 | ||
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2025-04-02 | Disposed to issuer | 20,000 | ||
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2025-04-02 | Disposed to issuer | 20,000 | ||
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2025-01-10 | Grant | 12,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2025-01-10 | Grant | 18,500 | $0.00 | |
|
Intra-Cellular Therapies Inc ITCI
Common Stock
|
2024-06-28 | Grant | 83 | $68.49 | 5,685 |
|
Intra-Cellular Therapies Inc ITCI
Common Stock
|
2024-06-23 | Option exercise | 1,567 | ||
|
Intra-Cellular Therapies Inc ITCI
Restricted Stock Units · derivative
|
2024-06-23 | Option exercise | 1,567 | $0.00 | |
|
Intra-Cellular Therapies Inc ITCI
Common Stock
|
2024-06-18 | Sell | 8,891 | $75.71 | 673,138 |
|
Intra-Cellular Therapies Inc ITCI
Common Stock
|
2024-06-18 | Option exercise | 20,000 | $16.86 | 337,200 |
|
Intra-Cellular Therapies Inc ITCI
Common Stock
|
2024-06-18 | Sell | 11,109 | $76.07 | 845,062 |
| showing 20 of 166 most recent transactions | |||||